These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 10321416

  • 1. Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study Investigators.
    Zuschke CA, Keys I, Munger MA, Carr AA, Marinides GN, Flanagan TL, Cushing DJ, Hayes JL, Michelson EL.
    Clin Ther; 1999 Mar; 21(3):464-74. PubMed ID: 10321416
    [Abstract] [Full Text] [Related]

  • 2. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
    Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL.
    Am J Cardiol; 1999 Aug 01; 84(3):289-93. PubMed ID: 10496437
    [Abstract] [Full Text] [Related]

  • 3. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators.
    Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL.
    Am J Cardiol; 1998 Oct 15; 82(8):961-5. PubMed ID: 9794352
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators.
    Kloner RA, Weinberger M, Pool JL, Chrysant SG, Prasad R, Harris SM, Zyczynski TM, Leidy NK, Michelson EL, Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators.
    Am J Cardiol; 2001 Mar 15; 87(6):727-31. PubMed ID: 11249891
    [Abstract] [Full Text] [Related]

  • 5. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.
    Himmelmann A, Keinänen-Kiukaanniemi S, Wester A, Redón J, Asmar R, Hedner T, Effect Study Group.
    Blood Press; 2001 Mar 15; 10(1):43-51. PubMed ID: 11332334
    [Abstract] [Full Text] [Related]

  • 6. A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II.
    Vidt DG, White WB, Ridley E, Rahman M, Harris S, Vendetti J, Michelson EL, Wang R, CLAIM Study Investigators.
    J Hum Hypertens; 2001 Jul 15; 15(7):475-80. PubMed ID: 11464257
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y, Asmar R.
    Am J Hypertens; 1999 Dec 15; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H, Ogihara T, Miyata Y, Sasai K, Totsuka N.
    Clin Ther; 2012 Apr 15; 34(4):838-48. PubMed ID: 22440192
    [Abstract] [Full Text] [Related]

  • 9. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL, Pêgo M, Marquez E, Pujol M, Olivan J, Alegría E, Sagastagoitia-Gorostiza JD, Gonzalez-Juanatey JR.
    Clin Drug Investig; 2007 Apr 15; 27(6):407-17. PubMed ID: 17506591
    [Abstract] [Full Text] [Related]

  • 10. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators.
    Asmar R, Lacourcière Y.
    J Hypertens; 2000 Nov 15; 18(11):1683-90. PubMed ID: 11081784
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.
    McInnes GT, O'Kane KP, Istad H, Keinänen-Kiukaanniemi S, Van Mierlo HF.
    J Hum Hypertens; 2000 Apr 15; 14(4):263-9. PubMed ID: 10805052
    [Abstract] [Full Text] [Related]

  • 15. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB, Jarvis B.
    Drugs; 2002 Apr 15; 62(5):787-816. PubMed ID: 11929332
    [Abstract] [Full Text] [Related]

  • 16. Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect.
    Elmfeldt D, George M, Hübner R, Olofsson B.
    J Hum Hypertens; 1997 Sep 15; 11 Suppl 2():S49-53. PubMed ID: 9331007
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide.
    Neldam S, Forsén B, Multicentre Study Group.
    Drugs Aging; 2001 Sep 15; 18(3):225-32. PubMed ID: 11302289
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy.
    Campbell M, Sonkodi S, Soucek M, Wiecek A.
    Clin Exp Hypertens; 2001 May 15; 23(4):345-55. PubMed ID: 11349825
    [Abstract] [Full Text] [Related]

  • 20. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
    Lee HY, Hong BK, Chung WJ, Lee BK, Lee SH, Jeon DW, Ahn YK, Kim D, Park CK, Kim SH, Jung HO, Kim BO, Choi D.
    Clin Ther; 2011 Aug 15; 33(8):1043-56. PubMed ID: 21831438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.